The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

1951 • 319,299 citations

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

1979 • 27,693 citations

Tissue sulfhydryl groups

1959 • 25,130 citations

Enzymatic Determination of Total Serum Cholesterol

1974 • 9,182 citations

Quantitative Determination of Serum Triglycerides by the Use of Enzymes

1973 • 3,206 citations

A RAPID AND PRECISE METHOD FOR THE DETERMINATION OF UREA

1960 • 2,678 citations

ON THE COLORIMETRIC DETERMINATION OF CREATININE BY THE JAFFE REACTION

1945 • 2,024 citations

Microvascular and Macrovascular Complications of Diabetes

2008 • 1,728 citations

Serum Creatinine as an Index of Renal Function: New Insights into Old Concepts

1992 • 1,549 citations

The Biology of Peroxisome Proliferator-Activated Receptors

2004 • 755 citations

Therapeutic Roles of Peroxisome Proliferator–Activated Receptor Agonists

2005 • 634 citations

Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity

2000 • 605 citations

Effect of Muraglitazar on Death and Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus

2005 • 559 citations

Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer.

1986 • 441 citations

Regulation of Connective Tissue Growth Factor Activity in Cultured Rat Mesangial Cells and Its Expression in Experimental Diabetic Glomerulosclerosis

2000 • 390 citations

Role of Advanced Glycation End Products in Diabetic Nephropathy

2003 • 344 citations

Regulation of Renal Lipid Metabolism, Lipid Accumulation, and Glomerulosclerosis in FVBdb/db Mice With Type 2 Diabetes

2005 • 281 citations

Cellular Lipid Metabolism and the Role of Lipids in Progressive Renal Disease

2004 • 269 citations

Cellular and Molecular Mechanisms of Proteinuria in Diabetic Nephropathy

2007 • 256 citations

Lipids and Renal Disease

2006 • 226 citations

PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice

2006 • 192 citations

PPAR dual agonists: Are they opening Pandora's Box?

2007 • 188 citations

Add-On Anti–TGF-β Antibody to ACE Inhibitor Arrests Progressive Diabetic Nephropathy in the Rat

2003 • 184 citations

Expression of Transforming Growth Factor-β and Type IV Collagen in Early Streptozotocin-Induced Diabetes

1997 • 180 citations

ACE Inhibitors Improve Diabetic Nephropathy Through Suppression of Renal MCP-1

2003 • 179 citations

Antioxidant defense system in diabetic kidney: A time course study

1997 • 172 citations

Angiotensin II and its receptors in the diabetic kidney

2000 • 159 citations

Rosiglitazone Improves Glomerular Hyperfiltration, Renal Endothelial Dysfunction, and Microalbuminuria of Incipient Diabetic Nephropathy in Patients

2005 • 154 citations

Role of TGF-β signaling in extracellular matrix production under high glucose conditions

2003 • 148 citations

Mechanisms of Diabetic Nephropathy

2006 • 142 citations

Accelerated Diabetic Nephropathy in Mice Lacking the Peroxisome Proliferator–Activated Receptor α

2006 • 134 citations

Structural-functional correlations of diabetic nephropathy

1994 • 133 citations

Upregulation of type I collagen by TGF-β in mesangial cells is blocked by PPARγ activation

2002 • 118 citations

Evaluation of blood urea nitrogen and serum creatinine concentrations as indicators of renal dysfunction: a study of 111 cases and a review of related literature.

1976 • 109 citations

Glitazones and Heart Failure

2003 • 97 citations

Plasma lipids and the progression of nephropathy in diabetes mellitus type II: Effect of ACE inhibitors

1995 • 97 citations

Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis

2003 • 94 citations

Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats

2004 • 85 citations

Association of Prolonged Hyperglycemia With Glomerular Hypertrophy and Renal Basement Membrane Thickening in the Goto Kakizaki Model of Non–Insulin-Dependent Diabetes Mellitus

2001 • 83 citations

Lipids and diabetic nephropathy

2006 • 80 citations

Pathophysiologic implications of proteinuria in a rat model of progressive glomerular injury.

1992 • 74 citations

Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy

2003 • 73 citations

Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy

2008 • 73 citations

Blood Urea Nitrogen and Creatinine

1986 • 69 citations

Medical Applications of Transforming Growth Factor-

2003 • 61 citations

Fenofibrate Treatment of Diabetic Rats Reduces Nitrosative Stress, Renal Cyclooxygenase-2 Expression, and Enhanced Renal Prostaglandin Release

2007 • 56 citations

Hyperglycemia and Hyperlipidemia Act Synergistically to Induce Renal Disease in LDL Receptor-Deficient BALB Mice

2003 • 54 citations

Renoprotective effects of fenofibrate in diabetic rats are achieved by suppressing kidney plasminogen activator inhibitor-1

2006 • 52 citations

After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study: Implications for Fenofibrate

2008 • 50 citations

Oxidized Low-Density Lipoprotein and Oxidative Stress in the Development of Glomerulosclerosis

2008 • 45 citations

Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes

1997 • 44 citations

Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy

2007 • 44 citations

Rosiglitazone stimulates the release and synthesis of insulin by enhancing GLUT-2, glucokinase and BETA2/NeuroD expression

2008 • 41 citations

Transcriptome Profiling and the Pathogenesis of Diabetic Complications

2003 • 37 citations

Adjuvant strategies for prevention of glomerulosclerosis

2006 • 32 citations

Goodbye glitazars?

2006 • 26 citations

Angiotensin II mediates LDL-induced superoxide generation in mesangial cells

2003 • 23 citations

Rosiglitazone prevents diabetes by increasing beta‐cell mass in an animal model of type 2 diabetes characterized by reduced beta‐cell mass at birth

2007 • 23 citations

Rosiglitazone Ameliorates Diabetic Nephropathy by Inhibiting Reactive Oxygen Species and Its Downstream-Signaling Pathways

2007 • 21 citations

Rosiglitazone Inhibits Early Stage of Glucolipotoxicity-Induced Beta-Cell Apoptosis

2008 • 17 citations

Determination of glucose in blood using glucose oxidase-peroxidase system and 8-hydroxyquinoline-p-anisidine.

1979 • 15 citations

Evidence for low-density lipoprotein–induced expression of connective tissue growth factor in mesangial cells

2005 • 14 citations

Diagnostische und pathophysiologische Aspekte der Nierenfunktionsbestimmung bei Tieren

1994 • 4 citations

[Effects of rosiglitazone on the expression of beta1, integrin and ICAM-1 in high glucose-induced rat glomerular mesangial cells].

2006 • 2 citations